Sympatho-renal axis in chronic disease

Clinical Research in Cardiology

Volumn 100, Issue 12, 2011, Pages 1049-1057

  Sobotka, Paul A ^a,b,g   Mahfoud, Felix ^c   Schlaich, Markus P ^d   Hoppe, Uta C ^e   Böhm, Michael ^c   Krum, Henry ^f  

^a OHIO STATE UNIVERSITY   (United States)

^b Ardian Inc   (United States)

^c SAARLAND UNIVERSITY   (Germany)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^e UNIVERSITY OF COLOGNE   (Germany)

^f MONASH UNIVERSITY   (Australia)

^g NONE   (United States)

Author keywords

Cardiorenal syndrome; Congestion; Heart failure; Hypertension; Insulin resistance; Renal denervation; Sleep apnea; Sympathetic nervous system; Symplicity HTN 2; Tachycardiac arrhythmias

Indexed keywords

GLUCOSE;

ADRENERGIC SYSTEM; BLOOD PRESSURE; CARDIORENAL SYNDROME; CHRONIC DISEASE; CONGESTIVE HEART FAILURE; DIURESIS; DYSLIPIDEMIA; ESSENTIAL HYPERTENSION; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; KIDNEY; KIDNEY DENERVATION; METABOLIC SYNDROME X; OBESITY; RADIOFREQUENCY ABLATION; REVIEW; SENSORY NERVE; SIGNAL TRANSDUCTION; SLEEP DISORDER; SYMPATHETIC NERVE;

EID: 84856006797     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-011-0335-y     Document Type: Review

References (69)

1. Esler M (2010) The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: The transition from mechanisms to medical management. J Appl Physiol 108:227-237
2. DiBona GF (2005) Physiology in perspective: The wisdom of the body. Neural control of the kidney. Am J Physiol Regul Integr Comp Physiol 289:R633-R641 (Pubitemid 41208425)
3. Esler M, Lambert G, Jennings G (1989) Regional norepinephrine turnover in human hypertension. Clin Exp Hypertens A 11(Suppl 1):75-89 (Pubitemid 19159111)
4. Huggett RJ, Scott EM, Gilbey SG, Stoker JB, Mackintosh AF, Mary DA (2003) Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension. Circulation 108:3097-3101 (Pubitemid 38031798)
5. DiBona GF, Sawin LL (1991) Role of renal nerves in sodium retention of cirrhosis and congestive heart failure. Am J Physiol 260:R298-R305
6. Mahfoud F, Böhm M (2010) Interventional renal sympathetic denervation-A new approach for patients with resistant hypertension. Dtsch Med Wochenschr 135:2422-2425
7. Vonend O, Marsalek P, Russ H, Wulkow R, Oberhauser V, Rump LC (2003) Moxonidine treatment of hypertensive patients with advanced renal failure. J Hypertension 21:1709-1717 (Pubitemid 37076355)
8. Schlaich MP, Lambert E, Kaye DM, Krozowski Z, Campbell DJ, Lambert G, Hastings J, Aggarwal A, Esler MD (2004) Sympathetic augmentation in hypertension: Role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 43:169-175 (Pubitemid 38174169)
9. Campese VM (1997) Neurogenic factors and hypertension in chronic renal failure. J Nephrol 10:184-187 (Pubitemid 27333193)
10. Ye S, Zhong H, Yanamadala V, Campese VM (2002) Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. Am J Hypertens 15:717-724 (Pubitemid 34804278)
11. Joles JA, Koomans HA (2004) Causes and consequences of increased sympathetic activity in renal disease. Hypertension 43:699-706 (Pubitemid 38405571)
12. Hausberg M, Kosch M, Harmelink P, Barenbrock M, Hohage H, Kisters K, Dietl KH, Rahn KH (2002) Sympathetic nerve activity in end-stage renal disease. Circulation 106:1974-1979 (Pubitemid 35176304)
13. Krum H, Sobotka P, Mahfoud F, Böhm M, Esler M, Schlaich M (2011) Device-based antihypertensive therapy: Therapeutic modulation of the autonomic nervous system. Circulation 123:209-215
14. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD (2009) Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 361:932-934
15. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M (2009) Catheter-based renal sympathetic denervation for resistant hypertension: A multicentre safety and proof-ofprinciple cohort study. Lancet 373:1275-1281
16. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (the symplicity htn-2 trial): A randomised controlled trial. Lancet 376:1903-1909
17. Doumas M, Douma S (2010) Renal sympathetic denervation: The jury is still out. Lancet 376:1878-1880
18. Fitzgerald PJ (2009) Is elevated noradrenaline an aetiological factor in a number of diseases? Auton Autacoid Pharmacol 29:143-156
19. Barajas L (1978) Innervation of the renal cortex. Fed Proc 37:1192-1201 (Pubitemid 8314398)
20. Esler M (2000) The sympathetic system and hypertension. Am J Hypertens 13:99S-105S (Pubitemid 30459894)
21. Esler M, Jennings G, Biviano B, Lambert G, Hasking G (1986) Mechanism of elevated plasma noradrenaline in the course of essential hypertension. J Cardiovasc Pharmacol 8(Suppl 5):S39-S43 (Pubitemid 16039090)
22. Esler M, Jennings G, Lambert G (1989) Noradrenaline release and the pathophysiology of primary human hypertension. Am J Hypertens 2:140S-146S (Pubitemid 19082354)
23. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI (1986) Norepinephrine spillover to plasma in patients with congestive heart failure: Evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73:615-621 (Pubitemid 16081418)
24. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R (2008) Cardiorenal syndrome. J Am Coll Cardiol 52:1527-1539
25. Aggarwal A, Esler MD, Morris MJ, Lambert G, Kaye DM (2003) Regional sympathetic effects of low-dose clonidine in heart failure. Hypertension 41:553-557 (Pubitemid 36314631)
26. Petersson M, Friberg P, Eisenhofer G, Lambert G, Rundqvist B (2005) Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure. Eur Heart J 26:906-913 (Pubitemid 40676571)
27. Dickstein K (2008) Esc guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: Application of natriuretic peptides. Reply. Eur Heart J 29:2388-2442
28. Gheorghiade M, Colucci WS, Swedberg K (2003) Beta-blockers in chronic heart failure. Circulation 107:1570-1575
29. Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Stancanelli B, Malatino LS (2002) Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 105:1354-1359 (Pubitemid 34260428)
30. Strojek K, Grzeszczak W, Gorska J, Leschinger MI, Ritz E (2001) Lowering of microalbuminuria in diabetic patients by a sympathicoplegic agent: Novel approach to prevent progression of diabetic nephropathy? JASN 12:602-605 (Pubitemid 32180031)
31. Hausberg M, Tokmak F, Pavenstadt H, Kramer BK, Rump LC (2010) Effects of moxonidine on sympathetic nerve activity in patients with end-stage renal disease. J Hypertension 28:1920-1927
32. Katholi RE (1985) Renal nerves and hypertension: An update. Fed Proc 44:2846-2850 (Pubitemid 16229758)
33. O'Hagan KP, Thomas GD, Zambraski EJ (1990) Renal denervation decreases blood pressure in doca-treated miniature swine with established hypertension. Am J Hypertens 3:62-64 (Pubitemid 20077356)
34. Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP (1995) Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 25:893-897
35. Norman RA Jr, Murphy WR, Dzielak DJ, Khraibi AA, Carroll RG (1984) Role of the renal nerves in one-kidney, one clip hypertension in rats. Hypertension 6:622-626 (Pubitemid 15210501)
36. Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S, Reid J, Van Zwieten PA (2007) The sympathetic nervous system and the metabolic syndrome. J Hypertension 25:909-920 (Pubitemid 46573105)
37. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM (2008) Resistant hypertension: Diagnosis, evaluation, and treatment: A scientific statement from the American Heart Association professional education committee of the council for high blood pressure research. Circulation 117:e510-e526
38. Yumino D, Redolfi S, Ruttanaumpawan P, Su MC, Smith S, Newton GE, Mak S, Bradley TD (2010) Nocturnal rostral fluid shift: A unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 121:1598-1605
39. Witkowski A, Prejbisz A, Florczak E, Kadziela J, Sliwinski P, Bielen P, Michalowska I, Kabat M, Warchol E, Januszewicz M, Narkiewicz K, Somers V, Sobotka P, Januszewicz A (2011) Effects of renal sympathetic denervation on blood pressure in patients with resistant hypertension and sleep apnea-A preliminary report. TRenD Meeting 2011, Frankfurt, Germany
40. Grassi G, Facchini A, Trevano FQ, Dell'Oro R, Arenare F, Tana F, Bolla G, Monzani A, Robuschi M, Mancia G (2005) Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension 46:321-325 (Pubitemid 41099164)
41. Lima NK, Abbasi F, Lamendola C, Reaven GM (2009) Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension. Am J Hypertens 22:106-111
42. Julius S, Gudbrandsson T, Jamerson K, Tariq Shahab S, Andersson O (1991) The hemodynamic link between insulin resistance and hypertension. J Hypertension 9:983-986
43. Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, Bohm M (2011) Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: A pilot study. Circulation 123:1940-1946
44. Schlaich MP, Straznicky N, Grima M, Ika-Sari C, Dawood T, Mahfoud F, Lambert E, Chopra R, Socratous F, Hennebry S, Eikelis N, Bohm M, Krum H, Lambert G, Esler MD, Sobotka PA (2011) Renal denervation: A potential new treatment modality for polycystic ovary syndrome? J Hypertension 29:991-996
45. Luippold G, Beilharz M, Muhlbauer B (2004) Chronic renal denervation prevents glomerular hyperfiltration in diabetic rats. Nephrol Dial Transplant 19:342-347 (Pubitemid 38195982)
46. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311:819-823 (Pubitemid 14035089)
47. Floras JS (2009) Sympathetic nervous system activation in human heart failure: Clinical implications of an updated model. J Am Coll Cardiol 54:375-385
48. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol heart failure study group. N Engl J Med 334:1349-1355 (Pubitemid 26152713)
49. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, Yusuf S (1990) Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the studies of left ventricular dysfunction (solvd). Circulation 82:1724-1729 (Pubitemid 20367975)
50. Jessup M, Costanzo MR (2009) The cardiorenal syndrome: Do we need a change of strategy or a change of tactics? J Am Coll Cardiol 53:597-599
51. Schrier RW (1990) Body fluid volume regulation in health and disease: A unifying hypothesis. Ann Internal Med 113:155-159 (Pubitemid 20218633)
52. Ring-Larsen H, Henriksen JH, Wilken C, Clausen J, Pals H, Christensen NJ (1986) Diuretic treatment in decompensated cirrhosis and congestive heart failure: Effect of posture. Br Med J (Clin Res Ed) 292:1351-1353 (Pubitemid 16081812)
53. Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, Saleheen D, Thompson A, Gudnason V, Sattar N, Danesh J (2009) B-type natriuretic peptides and cardiovascular risk: Systematic review and meta-analysis of 40 prospective studies. Circulation 120:2177-2187
54. Villarreal D, Freeman RH, Johnson RA, Simmons JC (1994) Effects of renal denervation on postprandial sodium excretion in experimental heart failure. Am J Physiol 266:R1599-R1604
55. Nozawa T, Igawa A, Fujii N, Kato B, Yoshida N, Asanoi H, Inoue H (2002) Effects of long-term renal sympathetic denervation on heart failure after myocardial infarction in rats. Heart Vessels 16:51-56 (Pubitemid 34110714)
56. Masaki H, Imaizumi T, Harasawa Y, Takeshita A (1994) Dynamic arterial baroreflex in rabbits with heart failure induced by rapid pacing. Am J Physiol 267:H92-H99
57. Clayton SC, Haack KK, Zucker IH (2011) Renal denervation modulates angiotensin receptor expression in the renal cortex of rabbits with chronic heart failure. Am J Physiol Renal Physiol 300:F31-F39
58. Steinback CD, Salzer D, Medeiros PJ, Kowalchuk J, Shoemaker JK (2009) Hypercapnic vs. Hypoxic control of cardiovascular, cardiovagal, and sympathetic function. Am J Physiol Regul Integr Comp Physiol 296:R402-R410
59. Chowdhury M, Adams S, Whellan DJ (2010) Sleep-disordered breathing and heart failure: Focus on obstructive sleep apnea and treatment with continuous positive airway pressure. J Card Fail 16:164-174
60. Holzer-Richling N, Holzer M, Herkner H, Riedmuller E, Havel C, Kaff A, Malzer R, Schreiber W (2011) Randomized placebo controlled trial of furosemide on subjective perception of dyspnoea in patients with pulmonary oedema because of hypertensive crisis. Eur J Clin Invest 41:627-634
61. Hasselblad V, Gattis Stough W, Shah MR, Lokhnygina Y, O'Connor CM, Califf RM, Adams KF Jr (2007) Relation between dose of loop diuretics and outcomes in a heart failure population: Results of the escape trial. Eur J Heart Fail 9:1064-1069 (Pubitemid 47451811)
62. Smilde TD, Damman K, van der Harst P, Navis G, Westenbrink BD, Voors AA, Boomsma F, van Veldhuisen DJ, Hillege HL (2009) Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure. Clin Res Card 98:121-129
63. Ellison DH (2001) Diuretic therapy and resistance in congestive heart failure. Cardiology 96:132-143 (Pubitemid 34114123)
64. Tomaselli GF, Zipes DP (2004) What causes sudden death in heart failure? Circ Res 95:754-763 (Pubitemid 39390577)
65. Del Pace S, Parodi G, Bellandi B, Zampini L, Venditti F, Ardito M, Antoniucci D, Gensini GF (2011) Anxiety trait in patients with stress-induced cardiomyopathy: A case-control study. Clin Res Card 100:523-529
66. Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost- Brama A, Lerebours G, Tavazzi L (2010) Ivabradine and outcomes in chronic heart failure (shift): A randomised placebocontrolled study. Lancet 376:875-885
67. Böhm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost- Brama A, Lerebours G, Tavazzi L (2010) Heart rate as a risk factor in chronic heart failure (shift): The association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 376:886-894
68. Moss AJ, Schwartz PJ, Crampton RS, Locati E, Carleen E (1985) The long qt syndrome: A prospective international study. Circulation 71:17-21 (Pubitemid 15164757)
69. Heusser K, Tank J, Engeli S, Diedrich A, Menne J, Eckert S, Peters T, Sweep FC, Haller H, Pichlmaier AM, Luft FC, Jordan J (2010) Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension 55:619-626